{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:50:18Z","timestamp":1768200618900,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1053\/jarr.2002.34844","type":"journal-article","created":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T19:51:36Z","timestamp":1030650696000},"page":"175-183","source":"Crossref","is-referenced-by-count":7,"title":["Use of vitamin D analogs in chronic renal failure"],"prefix":"10.1053","volume":"9","author":[{"given":"George","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jarr.2002.34844_NEWBIB1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hwska","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34844_NEWBIB2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jcem-54-1-172","article-title":"Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure","volume":"54","author":"Brown","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jarr.2002.34844_NEWBIB3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ki.1989.305","article-title":"Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis","volume":"36","author":"Dunlay","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1053\/jarr.2002.34844_NEWBIB6","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB7","first-page":"7","article-title":"1,25-dihroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: Effects of simultaneous protein and phosphorus restriction","volume":"25","author":"Lucas","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB8","first-page":"889","article-title":"Dietary phosphate restriction suppresses pre-pro PTH mRNA independent of 1,25-(OH)2D3 and ionized calcium in renal failure","volume":"5","author":"Slatopolsky","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihyroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insuffiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","article-title":"On the mechanism of secondary hyperparathyroidism in moderate renal insuffiency","volume":"61","author":"Llach","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jarr.2002.34844_NEWBIB11","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"key":"10.1053\/jarr.2002.34844_NEWBIB12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo by the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB14","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(78)92702-2","article-title":"Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol","volume":"2","author":"Christiansen","year":"1978","journal-title":"Lancet"},{"key":"10.1053\/jarr.2002.34844_NEWBIB16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000182088","article-title":"Effects of vitamin D metabolites and analogues on renal function","volume":"28","author":"Naik","year":"1981","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34844_NEWBIB17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J"},{"key":"10.1053\/jarr.2002.34844_NEWBIB18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2-vitamin D3 administration in moderate renal failure: a prospective double blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.me.43.020192.001303","article-title":"The use of 1,25-dihydroxyvitamin D3 in early renal failure","volume":"43","author":"Goodman","year":"1992","journal-title":"Annu Rev Med"},{"key":"10.1053\/jarr.2002.34844_NEWBIB20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: A disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM199008093230617","article-title":"Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis","volume":"323","author":"Fukagawa","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34844_NEWBIB22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.1991.110","article-title":"Regulation of parathyroid hormone synthesis in chronic renal failure in rats","volume":"39","author":"Fukagawa","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB23","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-dihyroxyvitamin D3 in the parathyroid glands of patients with renal failure","volume":"316","author":"Korkor","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34844_NEWBIB24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.1987.216","article-title":"Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia","volume":"32","author":"Merke","year":"1987","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1989.3","article-title":"1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs","volume":"35","author":"Brown","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB26","first-page":"216","article-title":"Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism","volume":"40","author":"Fischer","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB27","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1681\/ASN.V561344","article-title":"A comparison of oral and intravenous alfacalcidol in the treatment of uremic hyperparathyroidism","volume":"5","author":"Lee","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB28","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB29","first-page":"889","article-title":"Oral pulse calcitriol versus intravenous calcitriol therapy in treatment of hyperparathyroidism in hemodialysis patients","volume":"5","author":"Song","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000190286","article-title":"\u201cPulse oral\u201d versus intravenous calcitriol therapy in chronic hemodialysis patients: A prospective and randomized study","volume":"77","author":"Bacchini","year":"1997","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34844_NEWBIB31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","article-title":"Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism","volume":"44","author":"Reichel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000187887","article-title":"Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: A randomized prospective trial","volume":"67","author":"Herrmann","year":"1994","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34844_NEWBIB33","first-page":"854","article-title":"A randomized trial of pulse versus daily oral calcitriol in CAPD patients","volume":"5","author":"Moe","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB34","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/ndt\/11.supp3.96","article-title":"Guidelines for dosing of intravenous calcitriol in dialysis patients with hyperparathyroidism","volume":"11","author":"Fernandez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34844_NEWBIB35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(12)80831-6","article-title":"Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol","volume":"19","author":"Sprague","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB37","first-page":"324","article-title":"Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism","volume":"43","author":"Dressler","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ki.1994.375","article-title":"Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol","volume":"46","author":"Cannella","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0272-6386(95)90454-9","article-title":"The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism","volume":"26","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34844_NEWBIB42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.1993.350","article-title":"Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease","volume":"44","author":"Hutchinson","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000185718","article-title":"Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting Al(OH)3 intake: Emergence of an idiopathic adynamic bone disease not related to aluminum","volume":"53","author":"Moriniere","year":"1989","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34844_NEWBIB45","first-page":"152","article-title":"The role of bone biopsy in the diagnosis of renal osteodystrophy","volume":"13","author":"Sprague","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: The role of suppressed parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphorus product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB49","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34844_NEWBIB50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB51","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalitriol, suppresses parathyroid hormone synthesis and secretion","volume":"84","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34844_NEWBIB53","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/endo.133.3.8396012","article-title":"The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine","volume":"133","author":"Brown","year":"1993","journal-title":"Endocrinology"},{"key":"10.1053\/jarr.2002.34844_NEWBIB54","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/ndt\/11.supp3.121","article-title":"Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: Results of a preliminary study","volume":"11","author":"Kurokawa","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34844_NEWBIB55","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1053\/ajkd.1998.v32.pm9808142","article-title":"Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats","volume":"32","author":"Slatopolsky","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1\u03b1-hydroxyvitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34844_NEWBIB57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1,25-(OH)2D3, 19-Nor-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB58","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB59","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxyvitamin D3 and 19-nor-1,25-dihydroxyvitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/ajkd.2000.17667","article-title":"Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro","volume":"36","author":"Balint","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34844_NEWBIB61","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.V11101857","article-title":"1,25-Dihydroxy-19-nor-vitamin D2, a vitamin D analog with reduced bone resorbing activity in vitro","volume":"11","author":"Holliday","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB62","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-\u03b1-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34844_NEWBIB63","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol","volume":"38","author":"Sprague","year":"2001","journal-title":"Am J Kidney Disease"},{"key":"10.1053\/jarr.2002.34844_NEWBIB64","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/ajkd.2001.28112","article-title":"Paricalcitol dosing according to body weight or severity of hyperparathyroidism: A double-blind, multicenter, randomized study","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444902700381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444902700381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:47:36Z","timestamp":1622098056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444902700381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1073444902700381"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2002.34844","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}